These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 6100797

  • 1. Clinical course of GM2 gangliosidoses. A correlative attempt.
    Schulte FJ.
    Neuropediatrics; 1984 Sep; 15 Suppl():66-70. PubMed ID: 6100797
    [Abstract] [Full Text] [Related]

  • 2. Morphology of the gangliosidoses.
    Goebel HH.
    Neuropediatrics; 1984 Sep; 15 Suppl():97-106. PubMed ID: 6100800
    [Abstract] [Full Text] [Related]

  • 3. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G, Harden A.
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [Abstract] [Full Text] [Related]

  • 4. [Diagnosis of lysosomal storage diseases. Pathomorphologic and biochemical possibilities].
    August CH, Holzhausen HJ, Schmidt H, Stiller D, Seidlitz G, Zschiesche M.
    Zentralbl Allg Pathol; 1990 Sep; 136(5):443-53. PubMed ID: 2122616
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses.
    Kissell J, Rochmann C, Minini P, Eichler F, Stephen CD, Lau H, Toro C, Johnston JM, Krupnick R, Hamed A, Cox GF.
    Mol Genet Metab; 2024 Jul; 142(3):108512. PubMed ID: 38870773
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D, Higashine Y, Matsuoka K, Sakuraba H, Itoh K.
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pathobiology of cortical neurons in metabolic and unclassified amentias.
    Purpura DP.
    Res Publ Assoc Res Nerv Ment Dis; 1979 Mar; 57():43-68. PubMed ID: 217050
    [Abstract] [Full Text] [Related]

  • 9. The biochemical basis of gangliosidoses.
    Sandhoff K, Conzelmann E.
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract] [Full Text] [Related]

  • 10. [Biosynthesis and biodegradation of GM2 ganglioside].
    Hirabayashi Y, Kasakura H, Matsumoto M.
    Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
    [No Abstract] [Full Text] [Related]

  • 11. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
    Miklyaeva EI, Dong W, Bureau A, Fattahie R, Xu Y, Su M, Fick GH, Huang JQ, Igdoura S, Hanai N, Gravel RA.
    Brain Res; 2004 Mar 19; 1001(1-2):37-50. PubMed ID: 14972652
    [Abstract] [Full Text] [Related]

  • 12. [Sandhoff's and Tay-Sachs disease--based on our own cases].
    Kokot W, Raczyńska K, Krajka-Lauer J, Iwaszkiewicz-Bilikiewicz B, Wierzba J.
    Klin Oczna; 2004 Mar 19; 106(3 Suppl):534-6. PubMed ID: 15636260
    [Abstract] [Full Text] [Related]

  • 13. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM, Brooks SE, Amsterdam D, Oropello J, Schneck L.
    J Neurosci Res; 1980 Mar 19; 5(5):413-7. PubMed ID: 7441795
    [Abstract] [Full Text] [Related]

  • 14. The clinical aspects of adult hexosaminidase deficiencies.
    Federico A, Palmeri S, Malandrini A, Fabrizi G, Mondelli M, Guazzi GC.
    Dev Neurosci; 1991 Mar 19; 13(4-5):280-7. PubMed ID: 1840098
    [Abstract] [Full Text] [Related]

  • 15. Increased density of the thalamus on CT scans in patients with GM2 gangliosidoses.
    Brismar J, Brismar G, Coates R, Gascon G, Ozand P.
    AJNR Am J Neuroradiol; 1990 Mar 19; 11(1):125-30. PubMed ID: 2105593
    [Abstract] [Full Text] [Related]

  • 16. Synopsis: gangliosidoses.
    Schwab ME, Vassella F.
    Neuropediatrics; 1984 Sep 19; 15 Suppl():107-9. PubMed ID: 6100793
    [Abstract] [Full Text] [Related]

  • 17. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease.
    Purpura DP, Suzuki K.
    Brain Res; 1976 Oct 29; 116(1):1-21. PubMed ID: 824017
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M, Inui K, Hirabayashi Y, Tsukamoto H, Nishimoto J, Midorikawa M, Okada S, Yabuuchi H.
    J Inherit Metab Dis; 1989 Oct 29; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract] [Full Text] [Related]

  • 19. [Ultrastructure of inclusion bodies in gangliosidoses and ceroidolipofuscinosis. Summary of doctoral dissertation].
    Majdecki T.
    Neuropatol Pol; 1979 Oct 29; 17(2):323-31. PubMed ID: 220565
    [No Abstract] [Full Text] [Related]

  • 20. Neuropathology of late onset gangliosidoses. A review.
    Suzuki K.
    Dev Neurosci; 1991 Oct 29; 13(4-5):205-10. PubMed ID: 1817025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.